hematoxylin has been researched along with Mesothelioma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brcic, L; Kern, I; Quehenberger, F; Vlacic, G | 1 |
| Azimi, V; Banik, G; Chang, YH; Clayburgh, DR; Coussens, LM; Gray, JW; Kawashima, R; Means, C; Sivagnanam, S; Thibault, G; Tsujikawa, T | 1 |
| Yang, GC | 1 |
| De Young, BR; McGaughy, VR; Morgan, RL; Niemann, TH | 1 |
| Beer, TW; Carr, NJ; Pullinger, N; Whittaker, MA | 1 |
| Beck, G; Bernard, V; Martinet, N; Martinet, Y; Plenat, F; Schooneman, F; Vaillant, P; Vignaud, JM | 1 |
1 trial(s) available for hematoxylin and Mesothelioma
| Article | Year |
|---|---|
Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
Topics: Adenocarcinoma; Adult; Aged; Coloring Agents; Diagnosis, Differential; Epithelial Cells; Epithelium; Female; Hematoxylin; Humans; Hyperplasia; Indicators and Reagents; Lung Neoplasms; Male; Mesothelioma; Microvilli; Middle Aged; Pleural Effusion | 2003 |
5 other study(ies) available for hematoxylin and Mesothelioma
| Article | Year |
|---|---|
Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
Topics: Eosine Yellowish-(YS); Hematoxylin; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Observer Variation; Pathologists; Pleural Neoplasms; Prognosis; Reproducibility of Results | 2018 |
Robust Cell Detection and Segmentation for Image Cytometry Reveal Th17 Cell Heterogeneity.
Topics: Algorithms; Carcinoma, Pancreatic Ductal; Cell Nucleus; Diagnosis, Differential; Head and Neck Neoplasms; Hematoxylin; Humans; Image Cytometry; Image Interpretation, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pancreatic Neoplasms; Pleural Neoplasms; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Single-Cell Analysis; Squamous Cell Carcinoma of Head and Neck; Th17 Cells; Tumor Microenvironment | 2019 |
MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells.
Topics: 3,3'-Diaminobenzidine; Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Neoplasm; Carcinoma, Small Cell; Cell Membrane; Chromogenic Compounds; Coloring Agents; Diagnosis, Differential; Endopeptidase K; Epithelial Cells; Fixatives; Formaldehyde; Hematoxylin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Mesothelioma; Paraffin Embedding; Pleural Effusion, Malignant; Predictive Value of Tests; Sensitivity and Specificity | 1999 |
Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma.
Topics: Aged; Aged, 80 and over; Apoptosis; Biopsy; Eosine Yellowish-(YS); Female; Follow-Up Studies; Hematoxylin; Humans; In Situ Nick-End Labeling; Male; Mesothelioma; Middle Aged; Mitotic Index; Prognosis; Staining and Labeling; Survival Analysis | 2000 |
Mechanism for the recruitment of macrophages to cancer site. In vivo concentration gradient of monocyte chemotactic activity.
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Small Cell; Chemokine CCL2; Chemotactic Factors; Chemotaxis; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Inflammation; Lung Neoplasms; Macrophages; Male; Mesothelioma; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Tumor Cells, Cultured | 1992 |